Saturday, September 6, 2008 - 11:34PM EST

Review Articles

1. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.

Author
Altamura AC; Bobo WV; Meltzer HY;
Institution
Department of Psychiatry, University of Milan, Hospital Luigi Sacco, Via G.B. Grassi 74, 20157 Milan, Italy. c.altamura@hsacco.it
Journal
Int Clin Psychopharmacol. 2007 Sep;22(5):249-67.
Abstract URL
Click here to view abstract

2. Quetiapine: dose-response relationship in schizophrenia.

Author
Sparshatt A; Jones S; Taylor D;
Institution
Pharmacy Department, Maudsley Hospital, Denmark Hill, London, England.
Journal
CNS Drugs. 2008;22(1):49-68; discussion 69-72.
Abstract URL
Click here to view abstract

3. Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications.

Author
Elias AN; Hofflich H;
Institution
The University of California, Irvine Medical Center, Orange, CA 92868, USA. anelias@uci.edu
Journal
Am J Med. 2008 Feb;121(2):98-104.
Abstract URL
Click here to view abstract

4. Schizophrenia endophenotypes as treatment targets.

Author
Thaker GK;
Institution
University of Maryland School of Medicine, Maryland Psychiatric Research Center, Department of Psychiatry, PO Box 21247, Baltimore, MD 21228, USA. gthaker@mprc.umaryland.edu
Journal
Expert Opin Ther Targets. 2007 Sep;11(9):1189-206.
Abstract URL
Click here to view abstract

5. Paliperidone for schizophrenia.

Author
Dolder C; Nelson M; Deyo Z;
Institution
School of Pharmacy, Wingate University, Wingate, NC 28174, USA. cdolder@wingate.edu
Journal
Am J Health Syst Pharm. 2008 Mar 1;65(5):403-13.
Abstract URL
Click here to view abstract

6. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Author
Heres S; Davis J; Maino K; Jetzinger E; Kissling W; Leucht S;
Institution
Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Munich, Germany. s.heres@lrz.tum.de
Journal
Am J Psychiatry. 2006 Feb;163(2):185-94.
Abstract URL
Click here to view abstract

7. Evidence-based psychotherapy for schizophrenia.

Author
Dickerson FB; Lehman AF;
Institution
Sheppard Pratt Health System, Baltimore, Maryland 21204, USA.
Journal
J Nerv Ment Dis. 2006 Jan;194(1):3-9.
Abstract URL
Click here to view abstract

8. Cognitive behavior therapy for schizophrenia.

Author
Turkington D; Kingdon D; Weiden PJ;
Institution
Department of Psychiatry, Royal Victoria Infirmary, Newcastle-upon-Tyne, Tyne and Wear NE4 4LP, UK. douglas.turkington@ncl.ac.uk
Journal
Am J Psychiatry. 2006 Mar;163(3):365-73.
Abstract URL
Click here to view abstract

9. Schizophrenia: a review.

Author
Schultz SH; North SW; Shields CG;
Institution
Family Medicine Residency Program, University of Rochester School of Medicine and Dentistry, Rochester, New York 14620, USA. stephen_schultz@urmc.rochester.edu
Journal
Am Fam Physician. 2007 Jun 15;75(12):1821-9.
Abstract URL
Click here to view abstract

10. Schizophrenia.

Author
Picchioni MM; Murray RM;
Institution
King's College London, Institute of Psychiatry, Division of Psychological Medicine, London SE5 8AF. m.picchioni@iop.kcl.ac.uk
Journal
BMJ. 2007 Jul 14;335(7610):91-5.
Pages: 1 2